Data verified by Bookimed as of July 2026, based on patient requests and official quotes from 29 clinics worldwide. Median costs are based on real invoices (2025–2026) and updated monthly. Actual prices may vary.
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Lutetium-177 therapy upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lutetium-177 therapy and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lutetium-177 therapy journey.
Why we?
Your personal Bookimed medical coordinator
Supports you at every stage
Helps choose the right clinic and doctor
Ensures quick and convenient access to information
We're Temporarily Out of Lutetium-177 therapy Clinics in United States of America — Explore Trusted Options in Turkey and Save Up to 70%.
Prof. Dr. Cüneyt Türkmen has performed 1,100+ Lutetium-177 therapy procedures over 28 years of experience specializing in nuclear medicine. Treatment at Memorial Şişli typically costs around $6,500 per course – covering the therapy, 1 day hospitalization, and pre-treatment consultation. The JCI-accredited hospital uses PSMA PET-CT for precise therapy selection. Prof. Türkmen is an European Association of Nuclear Medicine member with 86+ scientific publications.
This package follows American standards through its affiliation with Johns Hopkins Medicine at the JCI-accredited Anadolu Medical Center. Dr. Kezban Berberoglu leads the evaluation and administration in a structured 4-day cycle: diagnostics on day two, Lu-177 PSMA therapy on day three, and a post-treatment scan on day four. The total cost is approximately $10,000, covering the therapy and associated medical supervision. Patients receive comprehensive support with free airport transfers, interpreters, and a medical second opinion to streamline their international care journey.
This LUTETHIUM THERAPY package targets PSMA-positive cancer with a dose capacity up to 200 mCi of Lutetium-177. Associate Professor Tamer Aksoy, a nuclear medicine specialist with 25+ years of experience and clinical research at the Netherlands Cancer Institute, delivers the treatment. It involves a planned protocol of 6–8 sessions at Hisar Hospital Intercontinental. Costs are approximately $8,800, which includes each therapy session, VIP transfers, a personal assistant, and translation services. The JCI-accredited Nuclear Medicine department provides PET/CT imaging validation for treatment planning.
Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.
Performs Lutetium-177 and Actinium-225 therapies for oncology patients.
Expert in PET-CT imaging using Gallium 68 for oncology cases.
Member of the Turkish Nuclear Medicine Association cardiology work group.
Works at an MTQUA Top 10 world hospital affiliated with Johns Hopkins.
Dr. Cuneyt Turkmen is a nuclear medicine specialist at Memorial Şişli Hospital in Istanbul. He has published over 80 scientific papers on oncology and imaging. Dr. Turkmen completed a professional fellowship at Sahlgrenska University Hospital in Sweden. He focuses on targeted radionuclide therapy for liver, prostate, and thyroid cancers.
Performs radioembolization and Lutetium-177 therapy for advanced cancer cases.
Expertise in Actinium-225 radiation and Amyloid PET scans.
Member of the European Association of Nuclear Medicine.
Works at a JCI-accredited hospital, the first in Turkey to reach this standard.
Dr. Tamer Aksoy is a nuclear medicine specialist at Hisar Hospital Intercontinental in Istanbul. He specializes in PET/CT examinations and radionuclide therapies. Dr. Aksoy completed clinical research as an observer at the Netherlands Cancer Institute in Amsterdam. He holds the title of Associate Professor.
Member of the European Association of Nuclear Medicine.
Expert in PET/CT imaging using Gallium 68 for precise diagnostics.
Focuses on radionuclide therapy for oncology patients.
Works at Hisar Hospital, which holds JCI accreditation for safety and quality.
Video Stories from Bookimed Patients
Niculcea
It’s a tough path — but we’re not walking it alone. And that means everything. Thanks to Bookimed again.
A certified medical writer with 10+ years of experience, developed Bookimed’s trusted content, backed by a Master’s in Philology and medical expert interviews worldwide.
General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
This page may feature information relating to various medical conditions, treatments, and healthcare services available in different countries. Please be advised that the content is provided for informational purposes only and should not be construed as medical advice or guidance. Please consult with your doctor or a qualified medical professional before starting or changing medical treatment.
Fast Facts about Lutetium-177 therapy
Lutetium-177 therapy
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.
Pros: Offers a high degree of precision, minimizing damage to healthy tissues. Demonstrates a favorable response rate in 60% of patients with neuroendocrine tumors.
Cons: Not suitable for all cancer types. Requires rigorous patient selection and monitoring due to potential kidney toxicity.
Effectiveness: Achieves 30-40% reduction in tumor size for responsive patients.
Duration: 1-2 hours per session.
Recovery: Initial recovery period of 1-2 days, with full recovery taking a few weeks.
Best for: Neuroendocrine tumors and prostate cancer with specific receptor expression.